APOTEX-MYCOPHENOLATE mycophenolate mofetil 250 mg capsule blister pack

Country: Аустралија

Језик: Енглески

Извор: Department of Health (Therapeutic Goods Administration)

Активни састојак:

mycophenolate mofetil, Quantity: 250 mg

Доступно од:

Arrotex Pharmaceuticals Pty Ltd

INN (Међународно име):

Mycophenolate mofetil

Фармацеутски облик:

Capsule

Састав:

Excipient Ingredients: croscarmellose sodium; indigo carmine; Gelatin; titanium dioxide; purified water; iron oxide red; magnesium stearate; sodium lauryl sulfate; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; Shellac; strong ammonia solution; iron oxide black; potassium hydroxide

Пут администрације:

Oral

Јединице у пакету:

100 capsules, 300 capsules

Тип рецептора:

(S4) Prescription Only Medicine

Терапеутске индикације:

Mycophenolate mofetil is indicated for the prophylaxis of solid organ rejection in adults receiving allogeneic organ transplants.,Mycophenolate mofetil is indicated for the prophylaxis of organ rejection in paediatric patients (2 to 18 years) receiving allogeneic renal transplants.

Резиме производа:

Visual Identification: Opaque blue cap and opaque pink body in Size 1 capsule containing white to off white powder. "M250" and "APO" are imprinted on capsules in black ink.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

Статус ауторизације:

Licence status A

Датум одобрења:

2011-11-08